Ruijia (Yixing) Technology Empowers Medical Innovation with One-Stop High-Performance Polymer Solutions
Mr. Lin Qinghua, founder of Rega (Yixing) Technologies Co., Ltd. (hereinafter referred to as “Rega Technologies”), is a Singapore-born Chinese. In 1995, he came to China as part of a Singaporean business delegation visiting the country. Optimistic about China’s development prospects and encouraged by favorable policy support, he made the decisive move to relocate his Singapore-based production facility to Wuxi, continuing to deepen his commitment to the research, development, and manufacturing of polymer material components.
Following the acquisition of his previous company, Mr. Lin Qinghua found himself unable to let go of his passion for the industry and remained determined to establish another platform and cultivate talent within the rubber polymer products sector. Driven by this vision, Mr. Lin founded Rega Technologies in 2010. Located in the Yixing Environmental Protection Science and Technology Park in Jiangsu Province, the company’s production and R&D base covers an area of over 80 mu.
Depending on specific requirements, Rega Technologies can provide customers with end-to-end solutions ranging from material formulation R&D and mold design and fabrication to final mass production,One-Stop Solution for Custom-Tailored Polymer Elastomer Parts and Components.The main products include components and assemblies made from various rubbers, silicone, liquid silicone rubber (LSR), plastics, and thermoplastic elastomers (TPE). The company serves industries such as healthcare, general wellness, electronic controls, 3C communications, automotive electronics, and consumer goods, with the healthcare and wellness sector accounting for 75–80% of its business. Its clientele includes industry-leading enterprises in China, Europe, and North America.
How Does a Custom Component Manufacturer Empower Medical Innovation? VCBeat Conducts an Exclusive Interview with Chen Hexi, General Manager of Rega Technologies
“In the field of polymer products, Rega Technologies hopesThe key to providing clients with solutions that solve problems and create value lies in differentiation.“We don’t just provide simple products or basic services; instead, we operate as an extension of our clients’ own polymer product R&D and manufacturing centers, covering the entire process from product concept to mass production, thereby becoming an irreplaceable partner in their minds,” introduced Chen Hexi.
One aspect of this differentiation is that Rega Technologies can provide customers with “early involvement and R&D companionship.”We engage at the early stages, including preliminary design, feasibility analysis, and formulation development, to provide multi-faceted support for customers’ early-stage product development in line with their needs. This support encompasses material validation, experimental tooling, design change verification, and sample validation. “Whether rapid R&D, validation, and mass production are required to meet time-to-market pressures, or medical products need to undergo years of long-term validation and clinical testing, we are committed to accompanying our clients throughout the entire journey, as we have consistently done.”
Chen Hexi noted that, for instance, many R&D enterprises in the medical field possess excellent design concepts and ideas. However, during the early stages of product development—particularly when developing a completely new product or seeking alternative materials—teams focused on device R&D may have relatively limited understanding of the performance and functional characteristics of the specific polymer materials used in components. Therefore, from aspects such as dimensions, design validation, material types and hardness, required performance, structure, mating methods with counterpart components, and mass production feasibility, product development and material selection require collaboration with component suppliers possessing comprehensive technical capabilities to conduct validation and even provide reference recommendations.
“Currently, most of the outstanding manufacturers in this field in China either do not have their core technologies located in China, or they mainly focus on mass-producing standard components. Due to considerations of profit margins and return on investment, few are willing to support the development of small-batch, diverse, and constantly changing non-standard components.”
Positioned around “early engagement and co-development,” Rega Technologies boasts independent teams of material formulation engineers, mold design and manufacturing engineers, project engineers, process engineers, and quality engineers dedicated to new product introduction. This integrated capability enables the company to participate in and support validation activities for various materials, design changes, and functional optimizations. Leveraging its domain expertise and technical experience, Rega serves as a materials specialist for its clients, delivering tangible value.
Taking material selection and formulation as an example, Rega Technologies’ materials team possesses extensive experience in proactively mitigating risks related to material biocompatibility, meeting toxicity requirements under ISO 10993 and/or USP standards, and fulfilling functional requirements such as sealing. This approach shortens the formulation validation cycle and enhances manufacturing feasibility. The company has already developed over a thousand proprietary material formulations and excels at customizing formulations based on customer needs and product positioning. In terms of tooling, stable quality and competitive costs are achieved through high-precision mold machining and optimized mold structure design.
The second step in differentiation lies in—in-house independent innovation.
Since its inception, “a passion for innovation and creativity” has been embedded in the corporate DNA of Rega (Yixing) Technologies Co., Ltd. From material formulation development, in-house mold design and manufacturing, and machining to process optimization and mass-production quality control, the team has established independent innovative solutions and a dedicated mass-production facility, ensuring the delivery of the most suitable customized solutions to clients. To date, Rega Technologies has collaborated with customers on multiple industry-first, and even global-first, product development projects.
In terms of process innovation, Rega Technologies' trump card isBreak down industry barriers, facilitate the exchange of process expertise across different sectors, mitigate the risk of being constrained by inertia-driven thinking rooted in limited experience during medical product development, and achieve “cross-disciplinary innovation” in products.“When we integrate cross-industry expertise, medical product innovation can achieve limitless creativity.” Chen Hexi noted that, for example, liquid silicone overmolding for wireless chip monitors and sealing solutions for portable syringes in the field of medical innovation can both draw on experience from the 3C industry’s wearable devices.
Meanwhile, Rega Technologies is also equipped with high-standard hardware. Mold manufacturing utilizes high-precision equipment imported from Switzerland, and production capabilities encompass rubber compression molding, rubber injection molding, micro-injection molding, liquid silicone rubber (LSR) injection molding, plastic injection molding, product surface coating, and ultrasonic welding. Most of the equipment is sourced from top-tier global manufacturers in the industry, enabling the company to meet the diverse product requirements of various customers.
In terms of quality systems, Rega (Yixing) Technologies Co., Ltd. holds ISO 13485, IATF 16949, ISO 9001, and ISO 14001 certifications. The medical-grade cleanrooms are classified as Class 300,000 and Class 100,000, and are equipped with proprietary DI (deionized) water and WFI (Water for Injection) production systems for product cleaning.
How to Maintain Team Morale and High-Standard Innovation?
Chen Hexi mentioned that Rega (Yixing) Technologies Co., Ltd. aspires to be a trusted partner in the hearts of its customers, an enterprise that empowers both clients and the industry, and a collaborator worthy of trust and reliance. To sustainably deliver such value, the company must maintain sufficient internal vitality, diligently focusing on enhancing its “internal capabilities” and “core philosophy.” “Internal capabilities” refer to technical strength, innovation capacity, quality assurance, and more, while “core philosophy” encompasses the team’s collective cognition, awareness, and ideals.
“Amidst the changes in the healthcare industry over the past few years, Rega Technologies has been minimally impacted. A key reason for this is our base of high-caliber, mission-driven clients, who are committed to continuous innovation, unwavering quality, and ongoing improvement. We are honored to stand alongside our clients, upholding the principles of ‘product excellence as our core, technological prowess as our shield,’ focusing on our own development, and maintaining our competitiveness.”
Adopting a long-termist business approach, Rega (Yixing) Technologies Co., Ltd. maintains a healthy state of steady, sustainable growth across its staffing, resource allocation, and cash flow management. “Our clients have consistently come through word-of-mouth referrals and strong recommendations from existing customers and partners. Looking ahead, Rega Tech aims to continue evolving, relentlessly pursuing unique value for our clients, the industry, and society at large, and becoming a trusted partner on the path to success for even more clients.”
At the end of the interview, Chen Hexi stated, “Rega Technologies aspires to become an enduring enterprise—one with the courage to pursue perfection. It may not appear great at present, but it is steadfastly walking the path toward greatness. We aim to attract customers, top talent, and partners just as flowers attract butterflies, nurturing one another through collaboration and achieving success together.”